Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Complement Therapeutics

Complement Therapeutics operates as a preclinical stage company.
2020
11-50
London, England, United Kingdom
BiotechnologynologyMedicalPrecision Medicine

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

84.31M

Last Funding Amount

78.66M

Last Funding Date

17-04-2023

Startup Stage

Early Stage

Lead Investors

Cambridge Innovation Capital, Panakes Partners, BioGeneration Ventures, Forbion Capital Partners, Seroba Life Sciences

Revenue

$1M to $10M